Translation of m-RNA
AssigneeDiatech, Inc.
InventorThomas M. A. Wilson
Life of this patent
Estimating the term…
Abstract
It has been found that the 5' regions of RNA viruses act as enhancers of translation of mRNA. The omega prime (.OMEGA.') sequence of Tobacco Mosaic Virus, derivatives and portions thereof, and 5' leader sequences of other RNA viruses can be ligated upstream of an appropriate mRNA or used in the form of cDNA in an expression vector. The translational enhancers are effective in many different types of expression system, for example plant cells, bacteria, and animal cells, and also in in vitro translation.
Claims5
DNA comprising two operatively linked subsequences, comprising:
- i) a first subsequence comprised of a sequence complementary to the .OMEGA.' sequence of tobacco mosaic virus, and
- ii) a second subsequence downstream of said first subsequence and comprised of a coding sequence heterologous to said virus;
- wherein, in mRNA produced by transcription of said first and second subsequences, mRNA complementary to said first subsequence is capable of enhancing translation of mRNA complementary to said second subsequence.
RNA comprising two operatively linked subsequences, comprising
- i) a first subsequence comprised of the .OMEGA.' sequence of tobacco mosaic virus, and
- ii) a second subsequence downstream of said first subsequence and comprised of a coding sequence heterologous to said virus;
- wherein said first subsequence is capable of enhancing translation of said second sequence.
A DNA vector comprising:
- i) a first subsequence comprised of a DNA sequence complementary to the .OMEGA.' sequence of tobacco mosaic virus, and
- ii) a second subsequence downstream of said first subsequence and comprised of a coding sequence heterologous to said virus;
- wherein said first subsequence is capable of enhancing the translation of mRNA corresponding to said coding sequence heterologous to said virus.
Dependencies are inferred from the claim text.